Mechanism and New. Lupus Erythematosus - Medication NSAIDs may be used for musculoskeletal and mild systemic complaints, although ibuprofen.

Slides:



Advertisements
Similar presentations
Lupus in children and teens
Advertisements

Disease Modifying Anti-Rheumatic Drugs (DMARDs) Immunomodulatory and immunosuppresive Xenobiotic – Gold salts – Azathioprine – Methotrexate Biological.
NSAIDs 1 st line of therapy in the medical management of RA.
SLE Systemic Lupus Erythematosus. Systemic lupus erythematosus (disseminated lupus erythematosus, lupus) is a chronic inflammatory connective tissue.
Systemic Lupus Erythematosus
1 IN THE NAME OF GOD. 2 SYSTEMIC LUPUS ERYTHEMATOSIS (SLE)
Systemic Lupus Erythematosus and Pregnancy:An Overview
Systemic Lupus Erythematosus and Pregnancy Andres Quiceno, MD Rheumatology.
Chair David S Pisetsky MD PhD Professor of Medicine and Immunology Duke University Medical Center Durham, NC Guests Ellen M Ginzler MD MPH Professor of.
© Copyright Annals of Internal Medicine, 2012 Ann Int Med. 157 (3): ITC2-1. * For Best Viewing: Open in Slide Show Mode Click on icon or From the View.
Systemic Lupus Erythematosus in children. Objectives Student will be able to define Lupus Student will be able list at least 3 clinical manifestation.
Abetimus Sodium (LJP 394) a synthetic Toleragen molecule consisting of four double-stranded oligodeoxyribonucleotides attached to nonimmunogenic polyethylene.
ISKDC. Primary nephrotic syndrome in children: Clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 69 Immunosuppressants.
LUPUS IN MEN. SLE: IMMUNOLOGIC FACTORS HALLMARK: POLYCLONAL IMMUNE HYPERACTIVITY WITH INCREASED PRODUCTION OF ANTIBODIES AGAINST “SELF” CONSTITUENTS.
Lupus Nephritis in Children Renal involvement in SLE: 30% - 70% Renal involvement in SLE: 30% - 70% Most diagnosis in adolescence, rare < 5y/o Most diagnosis.
Systemic Lupus Erythematosus
Gender Differences in Immune Response Females resist a variety of infections better than males ??? Females may reject transplanted organs more rapidly.
Systemic Lupus Erythematosus
Treatment of Rheumatoid Arthritis Then and Now
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student under Nephrology Division under the supervision and administration.
Diagnosis and Treatment of Aches and Pain in SLE
Systemic Lupus Erythematosus. Systemic Lupus Erythematosus (SLE) Multisystemic inflammatory chronic disease characterized by inflammation of blood vessels.
SLE SUBSETS Discoid lupus erythematosus (DLE)
Rheumatology Update 2008 R.W.Jackson,D.O.,F.A.C.O.I. Kirksville, MO.
OBJECTIVES NOT TO BE A NEPHROLOGIST
CHILDHOOD SLE IN THE 21 ST CENTURY THE STATE OF THE ART How do we get the best possible outcome Thomas J. A. Lehman MD Chief, Division of Pediatric rheumatology.
Systemic lupus erythematosus (SLE) is an autoimmune disease in which organs and cells undergo damage mediated by tissue- binding autoantibodies and immune.
Toxicity Interactions In Anagrams InfectionsPregnancy.
CONSTITUTIONAL SYMPTOMS Reassurance Rest/exercise NSAID Antimalarials Steroids (e.g. Prednisone
Nephrology Diseases & Chemotherapy. Idiopathic Nephrotic Syndrome (NS) Caused by renal diseases that increase the permeability across the glomerular filtration.
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
Systemic diseases and the kidney Dr I.Sagiv M.D Nephrology & Hypertension services Hadassah-Hebrew university medical center Jerusalem.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
SLE is an autoimmune disease of unknown etiology, characterized by acute& chronic inflammation of various tissues of the body. Autoimmune diseases are.
CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME UPDATE IN DIAGNOSIS.
Immunology of transplantation. Types of transplantation Autotransplantation –within one organism Allotransplantation- between one species Xenotransplantation-
Rheumatoid Arthritis Dr Chandini Rao Consultant Rheumatologist.
Advanced Therapies Lee R. Goldberg, MD, MPH Medical Director, Heart Failure and Cardiac Transplant Program University of Pennsylvania.
Lupus Nephritis Prof. Hafiz Ijaz Ahmad Department of Nephrology Allama Iqbal Medical College Lahore.
BY PROF. AZZA EL-MEDANY DR. OSAMA YOUSIF General Features & Conditions to use antirheumatic Low doses are commonly used early in the course of the disease.
SYSTEMIC LUPUS ERYTHEMATOSIS BY Dr. Hayam Hebah Associate professor of internal medicine AL-Maarefa College.
Esther Bokhobza Immunology.unideb.hu
Disease modified Anti-rheumatic drugs ( DMARD)
Dr lalooha. INTRODUCTION pregnancy in women with SLE carries a higher maternal and fetal risk compared with pregnancy in healthy women. The prognosis.
Dr.Noori Rheumatologist Dr.Noori Rheumatologist.  Twenty years ago, medical textbooks said that women with lupus should not get pregnant because of the.
Postpartum period in women with systemic lupus erythematosus BY DR KH ELMIZADEH.
Systemic lupus erythematous with lupus nephritis Diagnosis & Treatment
“Monitoring Systemic Lupus Erythematosus” Andres Quiceno, MD Presbyterian Hospital of Dallas.
Systemic lupus erythematosus
Management of SLE.
Lupus Nephritis Treatment
Treatment Goal of treatment reduce inflammation and pain
Management of SLE.
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for.
Treatment AIMS: Symptomatic: anti-inflammatories Sunbarrier creams
Nat. Rev. Nephrol. doi: /nrneph
Medicines for Children with Nephrotic Syndrome
Figure 4 Proposed therapy scheme for anti-LGI1 encephalitis
Membranous nephropathy: When and how to treat
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 2 Proposed approach to treating myositis-associated interstitial lung disease Figure 2 | Proposed approach to treating myositis-associated interstitial.
Target population/question
A B Anti-SRP-Myopathy Non-severe Severe*
Current induction and maintenance treatment choices for proliferative lupus nephritis. Current induction and maintenance treatment choices for proliferative.
Proteinuria trend versus time for seven patients who achieved remission with adrenocorticotropic hormone (ACTH). Proteinuria trend versus time for seven.
Networks of treatment comparisons for primary outcomes of SLE agents in patients with SLE. The size of the nodes (blue circles) corresponds to the number.
Lupus By: Brittni McClellan.
Presentation transcript:

Mechanism and New

Lupus Erythematosus - Medication NSAIDs may be used for musculoskeletal and mild systemic complaints, although ibuprofen has been noted to cause an aseptic meningitis in a small number of patients with SLE. Patients with mainly arthritic symptoms may be treated with weekly methotrexate, PO or SC Hydroxychloroquine often used to help control cutaneous manifestations, and is now the mainstay of SLE therapy Steroids often necessary to control systemic and renal manifestations Patients with renal disease often need immunosuppressive agents, such as cyclophosphamide (usually given as monthly IV boluses). Mycophenolate mofetil, cyclosporin, or azathioprine may also be used.

Lupus Erythematosus - Medication Patients with antiphospholipid antibodies are often treated with a baby aspirin daily. If they have already had a significant clotting event, they need stronger anticoagulation. Angiotensin converting enzyme inhibitors are often used to help prevent renal damage from proteinuria. Rituximab (anti-CD20 antibody) causes B-cell depletion and is now being used in SLE, especially for thrombocytopenia. Other biologic agents also being tested in lupus (e.g., antibodies to CD40 and C5)

Treatment of Proliferative Lupus Nephritis

Quality Measures for SLE